Ivan Alvarez - Related publications

Affiliations: 
University of California, Berkeley, Berkeley, CA 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Caulier A, Roussel M, Morel P, Lombion N, Branco B, Galtier J, Hulin C, Perrot A, Richez V, Michaud-Robert AV, Touzeau C, Doyen C, Mariette C, Caillot D, Harel S, et al. EPIDEMIOLOGICAL LANDSCAPE OF YOUNG MULTIPLE MYELOMA PATIENTS DIAGNOSED EARLIER THAN 40 YEARS: THE FRENCH EXPERIENCE. Blood. PMID 34479366 DOI: 10.1182/blood.2021011285   
2021 Iqbal L, Terlau TJ, Hernandez A, Woods K. Efficacy of Bamlanivimab in Reducing Hospitalization and Mortality Rates in COVID-19 Patients in a Rural Community. Cureus. 13: e16477. PMID 34430093 DOI: 10.7759/cureus.16477   
2021 Schaarschmidt BM, Wildgruber M, Kloeckner R, Nie J, Steinle V, Braat AJAT, Lohoefer F, Kim HS, Lahner H, Weber M, Theysohn J. Y radioembolization in the treatment of neuroendocrine neoplasms: Results of an international multicenter retrospective study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 34475236 DOI: 10.2967/jnumed.121.262561   
2021 Mehedinti AM, Capusa C, Andreiana I, Popa O, Mircescu G. Long-Term Intravenous Iron Therapy and Morbidity in Hemodialysis Patients. Maedica. 16: 194-199. PMID 34621339 DOI: 10.26574/maedica.2021.16.2.194   
2021 Wang L, Jia K, Li F, Zhang C, Feng G, Du J. Comparison of Improvement in 2-Year Survival Rate of Patients with Stage II-III Non-Small Cell Lung Cancer Treated with Different Durations of Chinese Patent Medicine: A Retrospective Cohort Study. Frontiers in Pharmacology. 12: 719802. PMID 34539404 DOI: 10.3389/fphar.2021.719802   
2021 Wang TY, Yi SH, Wang Y, Lyu R, Wang Q, Deng SH, Sui WW, Fu MW, Huang WY, Liu W, An G, Zhao YZ, Qiu LG. [Clinical analysis of fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of 43 cases of chronic lymphoblastic leukemia]. Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi. 42: 543-548. PMID 34455740 DOI: 10.3760/cma.j.issn.0253-2727.2021.07.003   
2021 Ingels A, Duc S, Bensalah K, Bigot P, Paparel P, Beauval JB, Salomon L, De La Taille A, Lang H, Nouhaud FX, Batista Da Costa J, Dariane C, Baumert H, Roupret M, Waeckel T, et al. Postoperative outcomes of elderly patients undergoing partial nephrectomy. Scientific Reports. 11: 17201. PMID 34433877 DOI: 10.1038/s41598-021-96676-y   
2021 Xu Y, Zheng M, Guo Q, Wang N, Wang R. Clinical Features and Survival Outcome of Early-Stage Primary Pulmonary MALT Lymphoma After Surgical Treatment. Frontiers in Surgery. 8: 713748. PMID 34422896 DOI: 10.3389/fsurg.2021.713748   
2021 Almonte M, Au XY, Ali M, Rajabalee N, Hasan S, Shibre T, Li Y, Kaplan AC. Association Between COVID-19 Outcomes and Patient Characteristics: A Study in an Inner-City Community Hospital. Cureus. 13: e17255. PMID 34540480 DOI: 10.7759/cureus.17255   
2021 Kosmopoulos A, Bhatt DL, Meglis G, Verma R, Pan Y, Quan A, Teoh H, Verma M, Jiao L, Wang R, Juliano RA, Kajil M, Kosiborod MN, Bari B, Berih AA, et al. A Randomized Trial of Icosapent Ethyl in Ambulatory Patients with COVID-19. Iscience. 103040. PMID 34462732 DOI: 10.1016/j.isci.2021.103040   
2021 Syed YA, Jiang C, Switchenko J, Kirmani K, Kelsey C, Khan MK. Improved Progression-Free Survival for Bulky and Non-Bulky Advanced Stage Diffuse Large B-Cell Lymphoma With Consolidative Radiation Therapy: A Bi-Institutional Analysis. Cureus. 13: e17107. PMID 34527492 DOI: 10.7759/cureus.17107   
2021 Gülbudak H, Karvar Ş, Soydan G, Tezcan Ülger S, Kandemir Ö, Tamer L, Altunkan AA, Özdemir AA, Aslan G. [Comparison of Real Time PCR Cycle Threshold Values in Symptomatic and Asymptomatic COVID-19 Patients]. Mikrobiyoloji Bulteni. 55: 435-444. PMID 34416808 DOI: 10.5578/mb.20219812   
2021 Kawasuji H, Morinaga Y, Tani H, Yoshida Y, Takegoshi Y, Kaneda M, Murai Y, Kimoto K, Ueno A, Miyajima Y, Fukui Y, Kimura M, Yamada H, Sakamaki I, Yamamoto Y. SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19. Journal of Medical Virology. PMID 34411312 DOI: 10.1002/jmv.27282   
2021 Usmani MA, Rahman AS, Jamal Q, Siddiqui M. Association of Type 2 Diabetes and Hepatic Encephalopathy in Chronic Liver Disease Patients. Cureus. 13: e17061. PMID 34522539 DOI: 10.7759/cureus.17061   
2021 Wu J, You K, Jiang Y, Shen T, Song J, Chen C, Liu Y. Prognostic role of pretreatment albumin-to-alkaline phosphatase ratio in locally advanced laryngeal and hypopharyngeal cancer: Retrospective cohort study. Journal of Cancer. 12: 6182-6188. PMID 34539891 DOI: 10.7150/jca.61445   
2021 Jiang B, Qi J, Song Y, Li Z, Tu M, Ping L, Liu Z, Bao H, Xu Z, Qiu L. Phase 1 clinical trial of the PI3Kδ inhibitor YY-20394 in patients with B-cell hematological malignancies. Journal of Hematology & Oncology. 14: 130. PMID 34425850 DOI: 10.1186/s13045-021-01140-z   
2021 Pant S, Goel A, Gangwar PK, Pandey A, Agarwal J, Gupta P. Effect of Clinical, Biochemical, and Genetic Variations on Medical Management in Filarial Chyluria: A Prospective Study at a Tertiary Care Centre in North India. Cureus. 13: e17292. PMID 34567855 DOI: 10.7759/cureus.17292   
2021 Jin Y, Ye D, Geng H, Yu YQ, Zhang XX, Peng SY, Li JT. [A new classification of intrahepatic cholangiocarcinoma based on actual anatomy:a series of 135 cases]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 59: 842-847. PMID 34619910 DOI: 10.3760/cma.j.cn112139-20210716-00313   
2021 Sehgal T, Gupta N, Kohli S, Khurana A, Dass J, Diwan S, A J M, Khan M, Aggarwal M, Subramanian A. A Prospective Study of Specialized Coagulation Parameters in Admitted COVID-19 Patients and Their Correlation With Acute Respiratory Distress Syndrome and Outcome. Cureus. 13: e17463. PMID 34589359 DOI: 10.7759/cureus.17463   
2021 Camus V, Rossi C, Sesques P, Lequesne J, Tonnelet D, Haioun C, Durot E, Willaume A, Gauthier M, Moles-Moreau MP, Antier C, Lazarovici J, Monjanel H, Bernard S, Tardy MP, et al. Outcomes after first-line immunochemotherapy for primary mediastinal B cell lymphoma patients: a LYSA study. Blood Advances. PMID 34461634 DOI: 10.1182/bloodadvances.2021004778   
2021 Chen C, Sun P, Sun XQ, Chen SY, Hang Yang, Wang Y, Li ZM. Primary treatment and recent survival trends in patients with primary diffuse large B-cell lymphoma of central nervous system, 1995-2016: A population-based SEER analysis. Hematological Oncology. PMID 34472655 DOI: 10.1002/hon.2918   
2021 Xu ZN, Huang JJ, Zhou J, Huang WS, Guo YJ, Cai MY, Zhou JW, Lin LT, Liang LC, Zhu KS. [Efficacy and safety of anti-PD-1 monoclonal antibody in advanced hepatocellular carcinoma after TACE combined with TKI therapy]. Zhonghua Nei Ke Za Zhi. 60: 630-636. PMID 34619840 DOI: 10.3760/cma.j.cn112138-20200928-00841   
2021 Ando Y, Kawaoka T, Kosaka M, Shirane Y, Johira Y, Miura R, Murakami S, Yano S, Amioka K, Naruto K, Kosaka Y, Uchikawa S, Kodama K, Fujino H, Nakahara T, et al. Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice. Cancers. 13. PMID 34439111 DOI: 10.3390/cancers13163958   
2021 Yu BQ, Jia SR, Gao YJ, Mao JF, Wang X, Nie M, Wu XY. [Analysis of differences in clinical and biochemical characteristics and treatment effects in patients with different genotypes of Prader-Willi syndrome]. Zhonghua Yi Xue Za Zhi. 101: 2760-2765. PMID 34551491 DOI: 10.3760/cma.j.cn112137-20210315-00649   
2021 Satouchi M, Nosaki K, Takahashi T, Nakagawa K, Aoe K, Kurata T, Sekine A, Horiike A, Fukuhara T, Sugawara S, Umemura S, Saka H, Okamoto I, Yamamoto N, Sakai H, et al. First-Line Pembrolizumab Versus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer: KEYNOTE-024 Japan Subset. Cancer Science. PMID 34543477 DOI: 10.1111/cas.15144   
2021 Abd-Elsalam S, Ahmed OA, Mansour NO, Abdelaziz DH, Salama M, Fouad MHA, Soliman S, Naguib AM, Hantera MS, Ibrahim IS, Torky M, Dabbous HM, El Ghafar MSA, Abdul-Baki EA, Elhendawy M. Remdesivir Efficacy in COVID-19 Treatment: A Randomized Controlled Trial. The American Journal of Tropical Medicine and Hygiene. PMID 34649223 DOI: 10.4269/ajtmh.21-0606   
2021 Shen L, Tian XJ, Liang RZ, Cheng Y, Kong XL, He F, Zhang C, Wang GA, Li SH, Lu HD, Sun SQ. [Clinical and imaging features of pneumonia: an analysis of 48 cases in China]. Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases. 44: 886-891. PMID 34565115 DOI: 10.3760/cma.j.cn112147-20210127-00082   
2021 Özkan G, Özyılmaz S, Bayrakçı N, Yıldırım I, Erdem I. The place of infectious markers in predicting culture positivity in patients with renal failure hospitalized with suspected infection. Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society For Apheresis, the Japanese Society For Apheresis, the Japanese Society For Dialysis Therapy. PMID 34494720 DOI: 10.1111/1744-9987.13731   
2021 Wang F, He MM, Yao YC, Zhao X, Wang ZQ, Jin Y, Luo HY, Li JB, Wang FH, Qiu MZ, Lv ZD, Wang DS, Li YH, Zhang DS, Xu RH. Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis. Cell Reports. Medicine. 2: 100383. PMID 34622226 DOI: 10.1016/j.xcrm.2021.100383   
2021 Blixt L, Bogdanovic G, Buggert M, Gao Y, Hober S, Healy K, Johansson H, Kjellander C, Mravinacova S, Muschiol S, Nilsson P, Palma M, Pin E, Smith CIE, Stromberg O, et al. Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients. Leukemia. PMID 34564699 DOI: 10.1038/s41375-021-01424-w   
2021 Nie RC, Chen GM, Wang Y, Yuan SQ, Zhou J, Duan JL, Liu WW, Chen S, Cai MY, Li YF. Association Between Body Mass Index and Survival Outcomes In Patients Treated With Immune Checkpoint Inhibitors: Meta-analyses of Individual Patient Data. Journal of Immunotherapy (Hagerstown, Md. : 1997). PMID 34456293 DOI: 10.1097/CJI.0000000000000389   
2021 Bauerle W, O'Laughlin M, Evans H. Improving Antibiotic Stewardship in Acute Appendicitis through Risk-Based Empiric Treatment Selection. Surgical Infections. PMID 34619064 DOI: 10.1089/sur.2021.144   
2021 Rautenberg C, Stölzel F, Röllig C, Stelljes M, Gaidzik V, Lauseker M, Kriege O, Verbeek M, Unglaub JM, Thol F, Krause SW, Hänel M, Neuerburg C, Vucinic V, Jehn CF, et al. Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia. Blood Cancer Journal. 11: 164. PMID 34608129 DOI: 10.1038/s41408-021-00558-5   
2021 Serban A, Mihai A, Dima A, Balaban DV, Jinga M, Jurcut C. The impact of the COVID-19 pandemic on patients with primary sjögren syndrome. Rheumatology International. PMID 34453578 DOI: 10.1007/s00296-021-04967-4   
2021 Wang Z, Ding J, Tang Y, Su Y, Cheng X, Yu Z, Ma X. Application of Various Methods to Evaluate the Postoperative Characteristics of Expanded Pedicled Deltopectoral Flap for Large Facial Scars. The Journal of Craniofacial Surgery. PMID 34560753 DOI: 10.1097/SCS.0000000000008221   
2021 Ting DSJ, Cairns J, Gopal BP, Ho CS, Krstic L, Elsahn A, Lister M, Said DG, Dua HS. Risk Factors, Clinical Outcomes, and Prognostic Factors of Bacterial Keratitis: The Nottingham Infectious Keratitis Study. Frontiers in Medicine. 8: 715118. PMID 34458289 DOI: 10.3389/fmed.2021.715118   
2021 Viana Filho JMC, Coêlho MC, Ribeiro ILA, Persuhn DC, Valença AMG, Oliveira NFP. ABCG2 polymorphism, age and leukocyte count may contribute to oral mucositis in oncopediatric patients. Brazilian Dental Journal. 32: 14-26. PMID 34614057 DOI: 10.1590/0103-6440202103768   
2021 Kim RY, Ma GJ, Park WK, Kim M, Park YG, Park YH. Clinical course after the onset of choroidal neovascularization in eyes with central serous chorioretinopathy. Medicine. 100: e26980. PMID 34449466 DOI: 10.1097/MD.0000000000026980   
2021 Gulati K, Edwards H, Prendecki M, Cairns TD, Condon M, Galliford J, Griffith M, Levy JB, Tam FWK, Tanna A, Pusey CD, McAdoo SP. Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis. Kidney International. PMID 34560140 DOI: 10.1016/j.kint.2021.08.025   
2021 Araujo-Castro M, Garcia Centeno R, López-García MC, Lamas C, Alvarez-Escola C, Calatayud Gutiérrez M, Blanco-Carrera C, de Miguel Novoa P, Valdés N, Gracia Gimeno P, Fernández-Ladreda MT, Mínguez Ojeda C, Percovich Hualpa JC, Mora M, Vidal O, et al. Risk factors for intraoperative complications in pheochromocytomas. Endocrine-Related Cancer. PMID 34379605 DOI: 10.1530/ERC-21-0230   
2021 Vaphiades MS, Grondines B, Cooper K, Gratton S, Doyle J. Diagnostic Evaluation of Visual Snow. Frontiers in Neurology. 12: 743608. PMID 34603194 DOI: 10.3389/fneur.2021.743608   
2021 Mallick T, Ramcharan MM, Dinesh A, Hasan M, Engdahl R, Ramcharan A. Clinical Course of Mechanically Ventilated COVID-19 Patients With Pneumothoraces. Cureus. 13: e16704. PMID 34466329 DOI: 10.7759/cureus.16704   
2021 Al-Yousuf N, Alaali H, Alsetri HM, Yusuf HE, Bhardwaj HK, Husain KA. Causes of Visual Impairment Among the Registered Visually Disabled: A Retrospective Study. Cureus. 13: e17988. PMID 34540512 DOI: 10.7759/cureus.17988   
2021 Marasco V, Carniti C, Guidetti A, Farina L, Magni M, Miceli R, Calabretta L, Verderio P, Ljevar S, Serpenti F, Morelli D, Apolone G, Ippolito G, Agrati C, Corradini P. T-cell immune response after mRNA SARS-CoV-2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies. British Journal of Haematology. PMID 34649298 DOI: 10.1111/bjh.17877   
2021 Pan YY, Xu SD, Fan YF, Tu J, Huang N, Yu YH, Cui SY, Le X, Xu P, Jin GY, Chen C. [Analysis of risk factors of early enteral nutrition intolerance in extremely severe burn patients]. Zhonghua Shao Shang Za Zhi = Zhonghua Shaoshang Zazhi = Chinese Journal of Burns. 37: 831-838. PMID 34645148 DOI: 10.3760/cma.j.cn501120-20210511-00180   
2021 Krishnan P, Tarricone A, Gee A, Farhan S, Kamran H, Kapur V, Gujja K, Kini A, Sharma S. Analysis of Interwoven Nitinol Stenting for the Treatment of Critical Limb Ischemia: Outcomes From an Average 3-Year Follow-up Period. Angiology. 33197211043406. PMID 34617824 DOI: 10.1177/00033197211043406   
2021 Brown LC, Desai K, Wei W, Kinsey EN, Kao C, George DJ, Rini BI, Ornstein MC, Zhang T. Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab. Journal For Immunotherapy of Cancer. 9. PMID 34518292 DOI: 10.1136/jitc-2021-003281   
2021 Chang SY, Kim J, Kim Y, Im BE, Chang BS, Lee CK, Kim H. The Fate of Lumbar Facet Cyst After Indirect Decompression Using Oblique Lateral Interbody Fusion in Degenerative Spondylolisthesis. Orthopedics. 44: 306-312. PMID 34590958 DOI: 10.3928/01477447-20210819-02   
2021 Yang X, Zhou K, Tao Y, Ge S, Shang W, Song K. Treatment efficacy and prognosis of pulmonary metastasizing ameloblastoma: a systematic review. International Journal of Oral and Maxillofacial Surgery. PMID 34462177 DOI: 10.1016/j.ijom.2021.07.016   
2021 Yang Y, Xia ZJ, Zhang WH, Fu CC, Bao L, Chen B, Ding KY, Wang SL, Luo J, Li BZ, Hua LM, Yang W, Zhou X, Wang L, Xu TH, et al. [The efficacy and safety profile of ixazomib/lenalidomide/dexamethasone in relapsed/refractory multiple myeloma: a multicenter real-world study in China]. Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi. 42: 628-634. PMID 34547867 DOI: 10.3760/cma.j.issn.0253-2727.2021.08.003